EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer

ConclusionExosomal delivery of miR-1915-3p can improve the chemotherapeutic efficacy of oxaliplatin in CRC cells by suppressing the EMT-promoting oncogenes PFKFB3 and USP2.

Source: Cancer Chemotherapy and Pharmacology - October 2, 2021 Category: Cancer & Oncology Source Type: research